Finance

Lists
Why is 688105 up 3.01%?
Dive Deeper
688105:SHA
Nanjing Vazyme Biotech Co Ltd
CN¥22.58
+3.01%
(+0.66) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688105...
Open
CN¥21.65
High
CN¥24.51
Low
CN¥20.92
Mkt. cap
11.67B
Avg. vol.
13.86M
Volume
17.14M
Dividend
1.70%
Quarterly dividend
CN¥0.10
Ex-dividend date
Jun 3, 2026
P/E ratio
2,746.96
52-wk high
CN¥29.16
52-wk low
CN¥12.89
EPS
CN¥0.01
No. of employees
3K
Open
CN¥21.65
High
CN¥24.51
Low
CN¥20.92
Mkt. cap
11.67B
Avg. vol.
13.86M
Volume
17.14M
Dividend
1.70%
Quarterly dividend
CN¥0.10
Ex-dividend date
Jun 3, 2026
P/E ratio
2,746.96
52-wk high
CN¥29.16
52-wk low
CN¥12.89
EPS
CN¥0.01
No. of employees
3K
News stories
From web sources and news partners
About Nanjing Vazyme Biotech Co Ltd
CEO-
Employees3K
FoundedMar 16, 2012
Headquarters-
SectorBiotechnology
Websitevazyme.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
425.48M
320.65M
379.80M
430.69M
Cost of goods sold
167.76M
92.87M
137.71M
108.00M
Cost of revenue
167.76M
92.87M
137.71M
108.00M
Research and development expenses
78.18M
67.69M
73.88M
76.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
208.11M
164.74M
184.25M
212.38M
Operating expense
323.26M
235.80M
261.29M
290.28M
Total operating expenses
491.02M
328.67M
399.00M
398.29M
Operating income
-65.54M
-8.02M
-19.20M
32.40M
Other non operating income
-4.62M
132.05K
-2.10M
-17.58M
EBT including unusual items
-21.16M
-4.00M
413.23K
3.87M
EBT excluding unusual items
-64.66M
-8.78M
-30.67M
34.06M
Income tax expense
5.06M
-5.99M
-3.44M
-6.72M
Effective tax rate
-23.92%
149.67%
-832.55%
-173.62%
Other operating expenses
20.96M
3.29M
3.00M
1.63M
Net income
-23.23M
4.18M
6.78M
13.26M
Net profit margin
-5.46%
1.30%
1.79%
3.08%
Earnings per share
-
-
-
-
Interest and investment income
6.73M
5.27M
3.35M
12.43M
Interest expense
-4.61M
-6.16M
-5.92M
-
Net interest expenses
2.12M
-885.26K
-2.57M
12.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.56M
14.95M
6.95M
55.38M
Gain or loss from assets sale
293.68K
-
-454.41K
454.41K
Upcoming events
AI content may include mistakes. Learn more
Google apps